A CYP26B1 Polymorphism Enhances Retinoic Acid Catabolism and May Aggravate Atherosclerosis

All-trans retinoic acid, controlled by cytochrome P450, family 26 (CYP26) enzymes, potentially has beneficial effects in atherosclerosis treatment. This study investigates CYP26 subfamily B, polypeptide 1 (CYP26B1) in atherosclerosis and the effects of a genetic polymorphism in CYP26B1 on retinoid c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Krivospitskaya, Olesya, Elmabsout, Ali Ateia, Sundman, Eva, Söderström, Leif Å, Ovchinnikova, Olga, Gidlöf, Andreas C, Scherbak, Nikolai, Norata, Giuseppe Danilo, Samnegård, Ann, Törmä, Hans, Abdel-Halim, Samy M, Jansson, Jan-Håkan, Eriksson, Per, Sirsjö, Allan, Olofsson, Peder S
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: ScholarOne 2012
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3388133/
https://ncbi.nlm.nih.gov/pubmed/22415012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00094
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller